Improve postoperative complication risk stratification
- Trial ID
- NCT03945968
- Official Title
- The Role of Concomitant Diseases in Postoperative Complications Risk Stratification - a Prospective Observational Multi-center Cohort Study
- Goal
- Improve postoperative complication risk stratification
- Status
- RECRUITING
- Sponsor
- Russian Federation of Anesthesiologists and Reanimatologists
- Study Type
- OBSERVATIONAL
- Enrollment
- 16000 participants
- Conditions
- Coronary Heart Disease, Anemia, Bronchial Asthma, Stroke, Epilepsy, Parkinson's Disease, Heart Rhythm Disorders, Alzheimer's Disease, Neuromuscular Diseases, Diabetes, Chronic Heart Failure, Chronic Obstructive Pulmonary Disease, Chronic Kidney Diseases
Plain-Language Summary
Trying to pin down how other long-term illnesses, including Parkinson's, change the chance of problems after abdominal surgery so doctors can better predict and plan care. Researchers are following about 16,000 adults across multiple hospitals who are having abdominal operations, recording their existing diseases, ASA anesthesia risk class, and any postoperative complications; it is a prospective observational study, so no new drugs or devices are given, just systematic data collection to improve risk models. Adults 18 and older undergoing abdominal surgery with ASA class 1 to 3 can join, while people who cannot have the needed factors assessed or who have acute events like massive bleeding, aspiration, severe bronchospasm, anaphylaxis, or malignant hyperthermia are excluded.
Locations
- The First City Clinical Hospital. n.a. E. E. Volosevich, Arkhangelsk, Russia
- Astrakhan State Medical University, Astrakhan, Russia
- Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine, Chelyabinsk, Russia
- South-Ural State Medical University, Chelyabinsk, Russia
- Chita state medical Academy of the Ministry of health of the Russian Federation, Chita, Russia
- Kazan State Medical University, Kazan', Russia
- Republic Clinical Hospital Ministry of Health care of the Republic of Tatarstan, Kazan', Russia
- Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
- Regional clinical hospital №2, Krasnodar, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute Regional Clinical Hospital named after S.V. Ochapovsky, Krasnodar, Russia
- Krasnoyarsk State Medical University named after Prof. V.F.Voino-Yasenetsky, Krasnoyarsk, Russia
- Burnasyan federal medical biophysical center of federal medical biological agency, Moscow, Russia
- City clinical hospital named after S.S. Yudin, Moscow, Russia
- City clinical hospital №1 named after N.I. Pirogov, Moscow, Russia
- City Clinical Hospital. n.a. F.I. Inozemtseva, Moscow, Russia
- FGBU "Central clinical hospital with polyclinic" of the President administration of the Russian Federation, Moscow, Russia
- Moscow cancer research Institute named after P. A. Herzen, Moscow, Russia
- Moscow City Oncological Hospital № 62, Moscow, Russia
- Moscow regional research clinical Institute named after M. F. Vladimirsky, Moscow, Russia
And 18 more locations.
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. Trying to pin down how other long-term illnesses, including Parkinson's, change the chance of problems after abdominal surgery so doctors can better predict and plan care. Researchers are following about 16,000 adults across multiple hospitals who are having abdominal operations, recording their existing diseases, ASA anesthesia risk class, and any postoperative complications; it is a prospective observational study, so no new drugs or devices are given, just systematic data collection to improve risk models. Adults 18 and older undergoing abdominal surgery with ASA class 1 to 3 can join, while people who cannot have the needed factors assessed or who have acute events like massive bleeding, aspiration, severe bronchospasm, anaphylaxis, or malignant hyperthermia are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 38 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 years and 6 months.